scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1136/PGMJ.68.800.406 |
P953 | full work available at URL | https://europepmc.org/articles/PMC2399344 |
https://europepmc.org/articles/PMC2399344?pdf=render | ||
P932 | PMC publication ID | 2399344 |
P698 | PubMed publication ID | 1437920 |
P2093 | author name string | M. Dancy | |
P2860 | cites work | Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol | Q28340406 |
Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy | Q33158267 | ||
Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts | Q33167437 | ||
Significance of the clinical presentation in ventricular tachycardia/fibrillation | Q33168061 | ||
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide | Q33169834 | ||
Multivariate analysis to simplify the differential diagnosis of broad complex tachycardia | Q33611225 | ||
A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex | Q34103324 | ||
Wide complex tachycardia: misdiagnosis and outcome after emergent therapy | Q34188140 | ||
Nonischemic sudden tachyarrhythmic death in atherosclerotic heart disease | Q37207550 | ||
Catheter ablation. Present role and projected impact on health care for patients with cardiac arrhythmias | Q37706885 | ||
Clinical management of patients with nonsustained ventricular tachycardia: what do we really know? | Q38020524 | ||
Values and limitations of programmed stimulation and ambulatory monitoring in the management of ventricular tachycardia | Q38194530 | ||
Ventricular tachycardia surgery: a review of the first decade and a suggested contemporary approach. | Q38216665 | ||
Automatic implantable cardioverter defibrillator. Current status | Q38674185 | ||
The role of exercise testing in evaluation of arrhythmias | Q39531531 | ||
The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions | Q40337547 | ||
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function | Q41186761 | ||
The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio | Q42032822 | ||
Reproducibility of exercise-induced ventricular arrhythmia in patients undergoing evaluation for malignant ventricular arrhythmia | Q42159984 | ||
Misuse of intravenous verapamil in patients with ventricular tachycardia | Q42202153 | ||
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy | Q42214611 | ||
Diagnosis of ventricular tachycardia: a clinical algorithm | Q42752278 | ||
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) | Q44631745 | ||
Surgical intervention for drug-resistant ventricular tachycardia | Q44671503 | ||
Angiographic findigs and prognostic indicators in patients resuscitated from sudden cardiac death | Q45028238 | ||
Recurrence of malignant ventricular arrhythmia after antiarrhythmic drug withdrawal | Q45156382 | ||
Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death | Q45195239 | ||
The Percutaneous Cardiac Mapping and Ablation Registry: final summary of results. | Q45961043 | ||
Long-term outcome with the automatic implantable cardioverter-defibrillator. | Q45996829 | ||
Antiarrhythmic efficacy of solitary beta-adrenergic blockade for patients with sustained ventricular tachyarrhythmias | Q46562014 | ||
Respective role of sympathetic tone and of cardiac pauses in the genesis of 62 cases of ventricular fibrillation recorded during Holter monitoring. | Q52547959 | ||
Misdiagnosis of chronic recurrent ventricular tachycardia. | Q52868601 | ||
Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both. | Q54352257 | ||
Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease | Q67898638 | ||
The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysis | Q68162787 | ||
Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic study | Q68178081 | ||
Significant variability in the mode of ventricular tachycardia induction and its implications for interpretation of acute drug testing | Q68497952 | ||
Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands | Q68534982 | ||
Effect of empiric antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims with coronary artery disease | Q68779133 | ||
Day-to-day reproducibility of antiarrhythmic drug trials using programmed extrastimulus techniques for ventricular tachyarrhythmias associated with coronary artery disease | Q68918905 | ||
The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia | Q69043867 | ||
The wide QRS tachycardia | Q69051628 | ||
A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring | Q69062283 | ||
The current status of ablation of cardiac conduction tissue and ectopic myocardial foci by transvenous electrical discharges | Q69543562 | ||
Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction | Q69562817 | ||
Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease | Q69598112 | ||
Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation | Q69639939 | ||
The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction | Q69749308 | ||
Electrophysiologic effects of epinephrine in humans | Q69826160 | ||
The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia | Q69881361 | ||
Determinants of prognosis in ventricular tachyarrhythmia patients without induced sustained arrhythmias | Q70023982 | ||
The arrhythmogenicity of antiarrhythmic agents | Q70101290 | ||
Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure | Q70198711 | ||
Effects of oral digoxin on ventricular ectopy and its relation to left ventricular function | Q70243860 | ||
Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy | Q71512942 | ||
Holter versus electrophysiologic studies in the management of malignant ventricular arrhythmias | Q71722022 | ||
Determinants of survival in patients with ventricular tachyarrhythmias | Q71747036 | ||
Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs | Q72664804 | ||
P433 | issue | 800 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ventricular tachycardia | Q56002 |
P304 | page(s) | 406-414 | |
P577 | publication date | 1992-06-01 | |
P1433 | published in | Postgraduate Medical Journal | Q7234294 |
P1476 | title | Diagnosis and management of ventricular tachycardia | |
P478 | volume | 68 |
Search more.